BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35897773)

  • 1. A Proteomic Platform Unveils the Brain Glycogen Phosphorylase as a Potential Therapeutic Target for Glioblastoma Multiforme.
    Ferraro G; Mozzicafreddo M; Ettari R; Corsi L; Monti MC
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.
    Zois CE; Hendriks AM; Haider S; Pires E; Bridges E; Kalamida D; Voukantsis D; Lagerholm BC; Fehrmann RSN; den Dunnen WFA; Tarasov AI; Baba O; Morris J; Buffa FM; McCullagh JSO; Jalving M; Harris AL
    Cell Death Dis; 2022 Jun; 13(6):573. PubMed ID: 35764612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.
    Abbadi S; Rodarte JJ; Abutaleb A; Lavell E; Smith CL; Ruff W; Schiller J; Olivi A; Levchenko A; Guerrero-Cazares H; Quinones-Hinojosa A
    Mol Cancer Res; 2014 Nov; 12(11):1547-59. PubMed ID: 25001192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel 5-Chloro-
    Huang Y; Li S; Wang Y; Yan Z; Guo Y; Zhang L
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer.
    Xia B; Zhang K; Liu C
    Technol Cancer Res Treat; 2020; 19():1533033820926592. PubMed ID: 32462986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity.
    Altinoz MA; Ucal Y; Yilmaz MC; Kiris İ; Ozisik O; Sezerman U; Ozpinar A; Elmaci İ
    Cancer Med; 2020 Aug; 9(16):5767-5780. PubMed ID: 32590878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
    Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Challenges and Opportunities in Treating Glioblastoma.
    Shergalis A; Bankhead A; Luesakul U; Muangsin N; Neamati N
    Pharmacol Rev; 2018 Jul; 70(3):412-445. PubMed ID: 29669750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
    Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-Type Glycogen Phosphorylase (PYGB) in the Pathologies of Diseases: A Systematic Review.
    Yang C; Wang H; Shao M; Chu F; He Y; Chen X; Fan J; Chen J; Cai Q; Wu C
    Cells; 2024 Feb; 13(3):. PubMed ID: 38334681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.
    Kavitha CV; Jain AK; Agarwal C; Pierce A; Keating A; Huber KM; Serkova NJ; Wempe MF; Agarwal R; Deep G
    Mol Carcinog; 2015 Nov; 54(11):1417-29. PubMed ID: 25252179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy.
    Rose M; Cardon T; Aboulouard S; Hajjaji N; Kobeissy F; Duhamel M; Fournier I; Salzet M
    Front Immunol; 2021; 12():746168. PubMed ID: 34646273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform.
    Olsen A; Harpaz Z; Ren C; Shneyderman A; Veviorskiy A; Dralkina M; Konnov S; Shcheglova O; Pun FW; Leung GHD; Leung HW; Ozerov IV; Aliper A; Korzinkin M; Zhavoronkov A
    Aging (Albany NY); 2023 Apr; 15(8):2863-2876. PubMed ID: 37100462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions.
    Sita G; Graziosi A; Hrelia P; Morroni F
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
    Mao H; Lebrun DG; Yang J; Zhu VF; Li M
    Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
    Philips KB; Kurtoglu M; Leung HJ; Liu H; Gao N; Lehrman MA; Murray TG; Lampidis TJ
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):349-61. PubMed ID: 24292700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.